Nanomedicine for intracellular therapy

FEMS Microbiology Letters

Volumn 332, Issue 1, 2012, Pages 1-9

  Ranjan, Ashish ^a   Pothayee, Nikorn ^b   Seleem, Mohamed N ^c   Boyle, Stephen M ^b   Kasimanickam, Ramanathan ^d   Riffle, Judy S ^b   Sriranganathan, Nammalwar ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

^d WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Drug delivery; Intracelluar infection; Nanoparticle

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; DOXYCYCLINE; GENTAMICIN; NALIDIXIC ACID; NANOPARTICLE; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIAL CLEARANCE; BACTERIAL SURVIVAL; BIOGENESIS; BRUCELLOSIS; CELL VACUOLE; COLONY FORMING UNIT; CYTOSKELETON; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; HUMAN; HYDROPHILICITY; LIPID BILAYER; MINIMUM INHIBITORY CONCENTRATION; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; PATIENT COMPLIANCE; PH; PHAGOCYTOSIS; PRIORITY JOURNAL; SALMONELLA; SALMONELLOSIS; TREATMENT FAILURE; TYPE III SECRETION SYSTEM; ZETA POTENTIAL;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG DELIVERY SYSTEMS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTRACELLULAR SPACE; NANOMEDICINE; NANOPARTICLES; SALMONELLA; SALMONELLA INFECTIONS;

EID: 84862255834     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2012.02566.x     Document Type: Article

References (88)

1. Abraham AM & Walubo A (2005) The effect of surface charge on the disposition of liposome-encapsulated gentamicin to the rat liver, brain, lungs and kidneys after intraperitoneal administration. Int J Antimicrob Agents 25: 392-397.
2. Abrahams GL & Hensel M (2006) Manipulating cellular transport and immune responses: dynamic interactions between intracellular Salmonella enterica and its host cells. Cell Microbiol 8: 728-737.
3. Ahmad Z, Sharma S & Khuller GK (2007) Chemotherapeutic evaluation of alginate nanoparticle-encapsulated azole antifungal and antitubercular drugs against murine tuberculosis. Nanomedicine 3: 239-243.
4. Alvarez-Ordonez A, Begley M, Prieto M, Messens W, Lopez M, Bernardo A & Hill C (2011) Salmonella spp. survival strategies within the host gastrointestinal tract. Microbiology 157: 3268-3281.
5. Asperilla MO, Smego RA Jr & Scott LK (1990) Quinolone antibiotics in the treatment of Salmonella infections. Rev Infect Dis 12: 873-889.
6. Bakowski MA, Braun V & Brumell JH (2008) Salmonella-containing vacuoles: directing traffic and nesting to grow. Traffic 9: 2022-2031.
7. Balland O, Pinto-Alphandary H, Pecquet S, Andremont A & Couvreur P (1994) The uptake of ampicillin-loaded nanoparticles by murine macrophages infected with Salmonella typhimurium J Antimicrob Chemother 33: 509-522.
8. Balland O, Pinto-Alphandary H, Viron A, Puvion E, Andremont A & Couvreur P (1996) Intracellular distribution of ampicillin in murine macrophages infected with Salmonella typhimurium and treated with (3H)ampicillin-loaded nanoparticles. J Antimicrob Chemother 37: 105-115.
9. Behravesh CB, Jones TF, Vugia DJ et al. (2011) Deaths associated with bacterial pathogens transmitted commonly through food: foodborne diseases active surveillance network (FoodNet), 1996-2005. J Infect Dis 204: 263-267.
10. Catron DM, Sylvester MD, Lange Y et al. (2002) The Salmonella-containing vacuole is a major site of intracellular cholesterol accumulation and recruits the GPI-anchored protein CD55. Cell Microbiol 4: 315-328.
11. Choi S & Lee KD (2008) Enhanced gene delivery using disulfide-crosslinked low molecular weight polyethylenimine with listeriolysin o-polyethylenimine disulfide conjugate. J Control Release 131: 70-76.
12. Clift MJ, Rothen-Rutishauser B, Brown DM et al. (2008) The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. Toxicol Appl Pharmacol 232: 418-427.
13. Connor BA & Schwartz E (2005) Typhoid and paratyphoid fever in travellers. Lancet Infect Dis 5: 623-628.
14. Cordeiro C, Wiseman DJ, Lutwyche P, Uh M, Evans JC, Finlay BB & Webb MS (2000) Antibacterial efficacy of gentamicin encapsulated in pH-sensitive liposomes against an in vivo Salmonella enterica serovar typhimurium intracellular infection model. Antimicrob Agents Chemother 44: 533-539.
15. Crump JA, Luby SP & Mintz ED (2004) The global burden of typhoid fever. Bull World Health Organ 82: 346-353.
16. Crump JA, Kretsinger K, Gay K et al. (2008) Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study. Antimicrob Agents Chemother 52: 1278-1284.
17. de Steenwinkel JE, van Vianen W, Ten Kate MT, Verbrugh HA, van Agtmael MA, Schiffelers RM & Bakker-Woudenberg IA (2007) Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice. J Antimicrob Chemother 60: 1064-1073.
18. Delehanty JB, Bradburne CE, Boeneman K et al. (2010) Delivering quantum dot-peptide bioconjugates to the cellular cytosol: escaping from the endolysosomal system. Integr Biol (Camb) 2: 265-277.
19. Dillen K, Vandervoort J, Van den Mooter G & Ludwig A (2006) Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. Int J Pharm 314: 72-82.
20. Ernst RK, Guina T & Miller SI (1999) How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses. J Infect Dis 179(Suppl 2): S326-S330.
21. Feglo PK, Frimpong EH & Essel-Ahun M (2004) Salmonellae carrier status of food vendors in Kumasi, Ghana. East Afr Med J 81: 358-361.
22. Fierer J, Hatlen L, Lin JP, Estrella D, Mihalko P & Yau-Young A (1990) Successful treatment using gentamicin liposomes of Salmonella Dublin infections in mice. Antimicrob Agents Chemother 34: 343-348.
23. Gamazo C, Lecaroz MC, Prior S, Vitas AI, Campanero MA, Irache JM & Blanco-Prieto MJ (2006) Chemical and biological factors in the control of Brucella and brucellosis. Curr Drug Deliv 3: 359-365.
24. Gamazo C, Prior S, Concepcion Lecaroz M et al. (2007) Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections. Expert Opin Drug Deliv 4: 677-688.
25. Garcia-del Portillo F, Nunez-Hernandez C, Eisman B & Ramos-Vivas J (2008) Growth control in the Salmonella-containing vacuole. Curr Opin Microbiol 11: 46-52.
26. Gelperina S, Kisich K, Iseman MD & Heifets L (2005) The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 172: 1487-1490.
27. Geoffroy C, Gaillard JL, Alouf JE & Berche P (1987) Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes Infect Immun 55: 1641-1646.
28. Gunn JS, Gonzalez-Escobedo G & Marshall JM (2011) Chronic and acute infection of the gall bladder by Salmonella Typhi: understanding the carrier state. Nat Rev Microbiol 9: 9-14.
29. Haraga A, Ohlson MB & Miller SI (2008) Salmonellae interplay with host cells. Nat Rev Microbiol 6: 53-66.
30. Hope BK, Baker R, Edel ED et al. (2002) An overview of the Salmonella enteritidis risk assessment for shell eggs and egg products. Risk Anal 22: 203-218.
31. Jain N, Rodriguez AC, Kimsawatde G, Seleem MN, Boyle SM & Sriranganathan N (2011) Effect of entF deletion on iron acquisition and erythritol metabolism by Brucella abortus 2308. FEMS Microbiol Lett 316: 1-6.
32. Kanungo S, Dutta S & Sur D (2008) Epidemiology of typhoid and paratyphoid fever in India. J Infect Dev Ctries 2: 454-460.
33. Kim BY, Rutka JT & Chan WC (2010) Nanomedicine. N Engl J Med 363: 2434-2443.
34. Kullberg M, Owens JL & Mann K (2010) Listeriolysin O enhances cytoplasmic delivery by Her-2 targeting liposomes. J Drug Target 18: 313-320.
35. Lecaroz C, Gamazo C & Blanco-Prieto MJ (2006) Nanocarriers with gentamicin to treat intracellular pathogens. J Nanosci Nanotechnol 6: 3296-3302.
36. Lee CM & Tannock IF (2006) Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration. Br J Cancer 94: 863-869.
37. Lee KD, Oh YK, Portnoy DA & Swanson JA (1996) Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes J Biol Chem 271: 7249-7252.
38. Lutwyche P, Cordeiro C, Wiseman DJ et al. (1998) Intracellular delivery and antibacterial activity of gentamicin encapsulated in pH-sensitive liposomes. Antimicrob Agents Chemother 42: 2511-2520.
39. Magallanes M, Dijkstra J & Fierer J (1993) Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis. Antimicrob Agents Chemother 37: 2293-2297.
40. Mainardes RM, Gremiao MP, Brunetti IL, da Fonseca LM & Khalil NM (2009) Zidovudine-loaded PLA and PLA-PEG blend nanoparticles: influence of polymer type on phagocytic uptake by polymorphonuclear cells. J Pharm Sci 98: 257-267.
41. Malik-Kale P, Jolly CE, Lathrop S, Winfree S, Luterbach C & Steele-Mortimer O (2011) Salmonella-at home in the host cell. Front Microbiol 2: 125.
42. Mandal M & Lee KD (2002) Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection. Biochim Biophys Acta 1563: 7-17.
43. Miki T, Okada N, Shimada Y & Danbara H (2004) Characterization of Salmonella pathogenicity island 1 type III secretion-dependent hemolytic activity in Salmonella enterica serovar Typhimurium. Microb Pathog 37: 65-72.
44. Mingeot-Leclercq MP, Brasseur R & Schanck A (1995) Molecular parameters involved in aminoglycoside nephrotoxicity. J Toxicol Environ Health 44: 263-300.
45. Mitev GM, Mellbye BL, Iversen PL & Geller BL (2009) Inhibition of intracellular growth of Salmonella enterica serovar Typhimurium in tissue culture by antisense peptide-phosphorodiamidate morpholino oligomer. Antimicrob Agents Chemother 53: 3700-3704.
46. Monack DM, Bouley DM & Falkow S (2004) Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFNgamma neutralization. J Exp Med 199: 231-241.
47. Moon C, Kwon YM, Lee WK, Park YJ & Yang VC (2007) In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide. J Control Release 124: 43-50.
48. Mugabe C, Azghani AO & Omri A (2005) Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother 55: 269-271.
49. Murata T, Tseng W, Guina T, Miller SI & Nikaido H (2007) PhoPQ-mediated regulation produces a more robust permeability barrier in the outer membrane of Salmonella enterica serovar typhimurium. J Bacteriol 189: 7213-7222.
50. Murillo O, Pachon ME, Euba G et al. (2009) Intracellular antimicrobial activity appearing as a relevant factor in antibiotic efficacy against an experimental foreign-body infection caused by Staphylococcus aureus J Antimicrob Chemother 64: 1062-1066.
51. Ong G, Wilson I, Smyth B & Rooney P (2007) Antimicrobial resistance in non-typhoidal salmonellas from humans in Northern Ireland, 2001-2003: standardization needed for better epidemiological monitoring. Epidemiol Infect 135: 675-680.
52. Page-Clisson ME, Pinto-Alphandary H, Chachaty E, Couvreur P & Andremont A (1998a) Drug targeting by polyalkylcyanoacrylate nanoparticles is not efficient against persistent Salmonella Pharm Res 15: 544-549.
53. Page-Clisson ME, Pinto-Alphandary H, Ourevitch M, Andremont A & Couvreur P (1998b) Development of ciprofloxacin-loaded nanoparticles: physicochemical study of the drug carrier. J Control Release 56: 23-32.
54. Parry CM, Vinh H, Chinh NT et al. (2011) The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica Serovar Typhi on the clinical response to ofloxacin therapy. PLoS Negl Trop Dis 5: e1163.
55. Pasmans F, Baert K, Martel A et al. (2008) Induction of the carrier state in pigeons infected with Salmonella enterica subspecies enterica serovar typhimurium PT99 by treatment with florfenicol: a matter of pharmacokinetics. Antimicrob Agents Chemother 52: 954-961.
56. Perrett CA & Jepson MA (2007) Applications of cell imaging in Salmonella research. Methods Mol Biol 394: 235-273.
57. Piddock LJ (2006) Multidrug-resistance efflux pumps - not just for resistance. Nat Rev Microbiol 4: 629-636.
58. Pinto-Alphandary H, Balland O, Laurent M, Andremont A, Puisieux F & Couvreur P (1994) Intracellular visualization of ampicillin-loaded nanoparticles in peritoneal macrophages infected in vitro with Salmonella typhimurium Pharm Res 11: 38-46.
59. Prior S, Gamazo C, Irache JM, Merkle HP & Gander B (2000) Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. Int J Pharm 196: 115-125.
60. Prost LR, Sanowar S & Miller SI (2007) Salmonella sensing of anti-microbial mechanisms to promote survival within macrophages. Immunol Rev 219: 55-65.
61. Quintanar-Guerrero D, Ganem-Quintanar A, Nava-Arzaluz MG & Pinon-Segundo E (2009) Silica xerogels as pharmaceutical drug carriers. Expert Opin Drug Deliv 6: 485-498.
62. Rajashekar R, Liebl D, Seitz A & Hensel M (2008) Dynamic remodeling of the endosomal system during formation of Salmonella-induced filaments by intracellular Salmonella enterica Traffic 9: 2100-2116.
63. Ranjan A, Pothayee N, Seleem MN, Sriranganathan N, Kasimanickam R, Makris M & Riffle JS (2009a) In vitro trafficking and efficacy of core-shell nanostructures for treating intracellular Salmonella infections. Antimicrob Agents Chemother 53: 3985-3988.
64. Ranjan A, Pothayee N, Seleem MN et al. (2009b) Antibacterial efficacy of core-shell nanostructures encapsulating gentamicin against an in vivo intracellular Salmonella model. Int J Nanomedicine 4: 289-297.
65. Ranjan A, Pothayee N, Seleem MN, Jain N, Sriranganathan N, Riffle JS & Kasimanickam R (2010a) Drug delivery using novel nanoplexes against a Salmonella mouse infection model. J Nanopart Res 12: 905-914.
66. Ranjan A, Pothayee N, Vadala TP et al. (2010b) Efficacy of amphiphilic core-shell nanostructures encapsulating gentamicin in an in vitro Salmonella and Listeria intracellular infection model. Antimicrob Agents Chemother 54: 3524-3526.
67. Reddy JA & Low PS (2000) Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. J Control Release 64: 27-37.
68. Ristuccia AM & Cunha BA (1982) The aminoglycosides. Med Clin North Am 66: 303-312.
69. Rosenberger CM, Gallo RL & Finlay BB (2004) Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. P Natl Acad Sci USA 101: 2422-2427.
70. Rudt S & Muller RH (1993) In-vitro phagocytosis assay of nano- and microparticles by chemiluminescense. III. Uptake of differently sized surface surface-modified particles, and its correlation to particle properties and in-vivo distribution. Eur J Pharm Sci 1: 31-39.
71. Saito G, Amidon GL & Lee KD (2003) Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential. Gene Ther 10: 72-83.
72. Sanhai WR, Sakamoto JH, Canady R & Ferrari M (2008) Seven challenges for nanomedicine. Nat Nanotechnol 3: 242-244.
73. Seleem MN, Munusamy P, Ranjan A, Alqublan H, Pickrell G & Sriranganathan N (2009a) Silica-antibiotic hybrid nanoparticles for targeting intracellular pathogens. Antimicrob Agents Chemother 53: 4270-4274.
74. Seleem MN, Jain N, Pothayee N, Ranjan A, Riffle JS & Sriranganathan N (2009b) Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline. FEMS Microbiol Lett 294: 24-31.
75. Solnik-Isaac H, Weinberger M, Tabak M, Ben-David A, Shachar D & Yaron S (2007) Quinolone resistance of Salmonella enterica serovar Virchow isolates from humans and poultry in Israel: evidence for clonal expansion. J Clin Microbiol 45: 2575-2579.
76. Subramanian G, Barry AO, Ghigo E, Raoult D & Mediannikov O (2011) Antibiotic susceptibility and intracellular localization of Diplorickettsia massiliensis FEMS Immunol Med Microbiol in press.
77. Swenson CE, Stewart KA, Hammett JL, Fitzsimmons WE & Ginsberg RS (1990) Pharmacokinetics and in vivo activity of liposome-encapsulated gentamicin. Antimicrob Agents Chemother 34: 235-240.
78. Tanaka M, Nakayama H, Haraoka M, Nagafuji T, Saika T & Kobayashi I (1998) Analysis of quinolone resistance mechanisms in a sparfloxacin-resistant clinical isolate of Neisseria gonorrhoeae Sex Transm Dis 25: 489-493.
79. Vakulenko SB & Mobashery S (2003) Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev 16: 430-450.
80. Vazquez-Boland JA, Kuhn M, Berche P et al. (2001) Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev 14: 584-640.
81. Vitas AI, Diaz R & Gamazo C (1996) Effect of composition and method of preparation of liposomes on their stability and interaction with murine monocytes infected with brucella abortus. Antimicrob Agents Chemother 40: 146-151.
82. Voetsch AC, Van Gilder TJ, Angulo FJ et al. (2004) FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis 38: S127-S134.
83. Wasaznik A, Grinholc M & Bielawski KP (2009) [Active efflux as the multidrug resistance mechanism]. Postepy Hig Med Dosw (Online) 63: 123-133.
84. Wasungu L & Hoekstra D (2006) Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release 116: 255-264.
85. Webb MS, Boman NL, Wiseman DJ et al. (1998) Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation. Antimicrob Agents Chemother 42: 45-52.
86. Xue JM, Tan CH & Lukito D (2006) Biodegradable polymer-silica xerogel composite microspheres for controlled release of gentamicin. J Biomed Mater Res B Appl Biomater 78: 417-422.
87. Zahr AS, Davis CA & Pishko MV (2006) Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). Langmuir 22: 8178-8185.
88. Zuhorn IS, Bakowsky U, Polushkin E, Visser WH, Stuart MC, Engberts JB & Hoekstra D (2005) Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency. Mol Ther 11: 801-810.